欢迎来到西安迈博睿(Mabioway)生物科技有限公司 Call: 15339069646 | E-mail: info@mabioway.cn 在线留言 |

服务热线

15339069646
网站导航
当前位置: 首页 > 产品展示 > 抗体产品 > 一抗 > 其他抗体
其他抗体

Anti-Rituximab (variable region) mAbs

简要描述:

​This antibody is an idiotypic antibody against rituximab. It shows no cross-reactivity with other CD20-specific antibodies. Rituximab is a monoclonal antibody against CD20 used to treat autoimmune diseases and some types of cancer.

产品参数:

Cat. No.:MABL-2838

Species:Engineer

Species Reactivity:Human

Type:Recombinate

Application:Blocking, functional assay, IP, SPR, WB, ELISA, FC

详细介绍

Key features and   details


Cat. No.

MABL-2838

Name

Anti-Rituximab (variable region) mAbs

Clone No.

AFD- MB2A4

From

Recombinant Antibody

Isotype

Engineer antibody

Application

Blocking, functional assay, IP, SPR, WB,   ELISA, FC

Species Reactivity

Human

Basic Information


Specificity

This antibody is an idiotypic antibody   against rituximab. It shows no cross-reactivity with other CD20-specific   antibodies. Rituximab is a monoclonal antibody against CD20 used to treat   autoimmune diseases and some types of cancer.

Alternative Name

Rituximab; Rituxan

UniProt


Immunogen

The rat version of this antibody was raised   by immunizing a rat with the F(ab)2 fragment of Rituximab.

Application Notes

To develop an ELISA to measure rituximab, an   ELISA was performed on solutions of rituximab using the rat version of this antibody. The ELISA could be used to quantify rituximab at concentrations between 0.125 and 50 μg/mL. Furthermore, the binding strength of this antibody to rituximab was measured using SPR. It showed a Kd value of 0.6 nM.   Finally, a competition assay between this antibody and a P20 peptide was   performed to determine whether P20 could block the binding of this antibody. A decrease in binding was indeed noted (Blasco et al., 2007; PMID: 17651747).   To characterize this antibody, an ELISA was performed on diluted samples of   rituximab using the rat version of this antibody. Furthermore, flow cytometry   was used to detect rituximab on the surface of CD20-positive cells using this   antibody. The antibody was bound to rituximab-coated cells and showed no   cross-reactivity with other CD20-binding antibodies. The ability of this   antibody to block rituximab from binding B cells was also shown (Cragg et al.,   2004; PMID: 15213098).

Antibody First   Published

Cragg et al. A new anti-idiotype antibody   capable of binding rituximab on the surface of lymphoma cells Blood. 2004 Oct 15;104(8):2540-2. PMID:15213098

Note on publication

An anti-idiotype antibody against rituximab   was raised and characterized.

COA Information For reference only, actual COA shall prevail

Size

100 μg Purified   antibody.

Concentration

1 mg/ml.

Purification

Protein A affinity   purified

Buffer

PBS with 0.02% Proclin   300.

Concentration

1 mg/ml.

Storage   Recommendation

Store at 4⁰C for up to 3   months. For longer storage, aliquot and store at - 20⁰C.


 


服务咨询

留言框

  • 标题:

  • 留言内容:

  • 您的单位:

  • 您的姓名:

  • 联系电话:

  • 常用邮箱:

  • 详细地址:

上一篇: Anti-Ricin mAbs

下一篇: Anti-RNA hairpin mAbs

推荐产品

联系我们

Copyright © 2012-2029 西安迈博睿(Mabioway)生物科技有限公司 版权所有

地址:陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层

电话:15339069646 邮箱:info@mabioway.cn

陕ICP备2021006339号